November 2008


The Supreme Court will decide whether federal law preempts product liability suits at the state level if the warning labels are FDA-approved.
The report says unique identifiers would reduce errors and protect privacy, but privacy watchdogs are not convinced.
Delegates have begun looking at alternative pay options to replace the current formula.
Delegates said bans on both practices would promote safety and protect patients.
The AMA will ask for a one-year hold on the Joint Commission rule. Delegates seek to shift the focus to behavior that harms patients.

Next Page »

Calling Card